Andrew Kaplan to Illuminate Key Developments in Drug and Medical Device Litigation at Upcoming Industry Panel

Legal expert Andrew Kaplan is slated to address key developments in drug and medical device litigation at an upcoming panel discussion titled “Drug and Medical Device Litigation Year in Review.” Kaplan, a seasoned attorney within this specialized field, will examine pivotal changes and delve into their implications for future legal practices and proceedings. The panel, set to convene soon, aims to dissect significant court rulings from the past year that have shaped the landscape of litigation concerning pharmaceuticals and medical devices. These decisions, often setting precedence, have played a crucial role in shaping the legal … Read more

Surge in Bard PowerPort Lawsuits: Over 1,100 Cases Pending in Arizona MDL as Allegations of Device Malfunction Intensify

PHOENIX, Ariz. — Over 1,100 lawsuits have been filed against the makers of Bard PowerPort, a medical device used for venous access during medical treatments, which plaintiffs claim is prone to fracturing and causing serious injuries. These cases are currently centralized in multidistrict litigation (MDL) before Judge David G. Campbell in Arizona, signifying a growing legal battle against Becton Dickinson, the company that owns Bard. The ongoing litigation has seen a rapid increase in the number of cases. From having no pending lawsuits in the MDL in October 2023, numbers surged to 1,112 active lawsuits … Read more

Trailblazing Attorney Leads Groundbreaking Litigation in High-Stakes Drug and Medical Device Cases

NEW YORK — Jonathan M. Sedgh, a prominent figure in the legal battle against pharmaceutical and medical device giants, has garnered significant attention for his role as a product liability lawyer at Morgan & Morgan. Sedgh is renowned for filing landmark lawsuits on behalf of clients who have suffered due to insufficiently tested or disclosed side effects of medical products. In August 2023, Sedgh made headlines when he and his team initiated the first lawsuit concerning the drugs Ozempic and Mounjaro, which was filed in Louisiana. The case revolves around a woman who developed gastroparesis, … Read more

Insulet Wins Massive $452 Million in Trade Secret Lawsuit Against EOFlow Over Insulin Device Innovations

BOSTON — In a landmark legal decision, Insulet Corp., headquartered in Massachusetts, triumphed in a major trade secrets lawsuit against South Korea-based EOFlow Co. Ltd., with a federal jury awarding the U.S. medical device maker a colossal $452 million. The verdict, reached on Tuesday, marks a significant moment in the realm of intellectual property rights within the highly competitive medical device industry. Insulet Corp. has been developing its innovative OmniPod insulin pump since the early 2000s, a device that has significantly impacted the management of diabetes through its advanced, wearable technology. The lawsuit emerged following … Read more